The choice between Semaglutide, Tirzepatide, and Retatrutide depends on factors like: Your weight loss goals Existing health conditions (e.g., Type 2 Diabetes) How your body responds to GLP-1 medications Your providers recommendations All three medications are highly effective, but Retatrutide may offer the most significant weight loss due to its triple-action mechanism
- Keep a journal to track any side effects or reactions to the medication
In the United States, from 2011 to 2014, approximately 35% of premenopausal women aged 20 to 59 were obese, and about 20% of BC cases occurred in women with obesity [4]
Retatrutide Nexaph lab test Independent lab test of Retatrutide from Nexaph
A 4mg dose = 0.4mL = 40 units
56-OR: A long-acting glucose-dependent insulinotropic polypeptide receptor agonist shows weight loss without nausea or vomiting